RNA sequencing identifies human placental IL3RA as a potential predictor of adverse cardiovascular outcomes in patients with severe preeclampsia

Mortality from preeclampsia (PE) and PE-associated morbidities are 3-to 5-fold higher in persons of African ancestry than in those of Asian and European ancestries. The placenta is central to the etiology of PE. However, how the placenta contributes to worse PE outcomes in persons of African ancestry is yet to be fully elucidated. Objective: We aimed to identify molecular pathways that are unique or enriched in placentas of parturient persons of African ancestry with PE with severe features (sPE) compared to those of Asian and European ancestry with sPE. Study design: Bulk RNA sequencing was performed on 50 placentas from parturient persons with sPE of African (n=9), Asian (n=18) and European (n=23) ancestries and 73 normotensive controls of African (n=9), Asian (n=15) and European (n=49) ancestries. Results: Metabolism, hormone regulation and hypoxia/angiogenesis genes, previously described to be upregulated in PE, including: LEP, PAPPA2, INHA, FSTL3, FLT1, PHYHIP and ENG, were upregulated in sPE across ancestries, with high expression of FSTL3 being additionally associated with intrauterine growth restriction (p = .0047). Notably, the upregulation of, FLT1, LEP and PHYHIP was significantly higher in sPE placentas from parturient persons of African versus Asian ancestry (p = .0.35, .020 and .012 respectively). Genes associated with allograft rejection and adaptive immune response were upregulated in placentas from parturients of African ancestry but not in those of Asian and European ancestries. Among the allograft rejection/adaptive immune response genes, IL3RA was of particular interest because the patient with the highest placental IL3RA level, a woman of African ancestry with IL3RA levels 4.5-fold above the average for African ancestry parturients with sPE, developed postpartum cardiomyopathy, and was the only patient out of 123, that developed this condition. Interestingly, the sPE patients with the highest IL3RA levels among parturients of Asian and European ancestries developed unexplained tachycardia peripartum, necessitating echocardiography in the European ancestry patient. The association between elevated placental IL3RA levels and unexplained tachycardia or peripartum cardiomyopathy was found to be significant in the 50 sPE patients (p = .0005). Conclusions: Placentas from parturients of African ancestry express higher levels of metabolism (LEP) and hypoxia/angiogenesis (FLT1) genes, as well as allograft rejection/adaptive immune response genes, including IL3RA. High placental expression of IL3RA may predict worse maternal cardiovascular outcomes, including peripartum cardiomyopathy. Studies evaluating placental IL3RA levels in peripartum cardiomyopathy cohorts are therefore warranted, as are broader studies evaluating placental factors in maternal cardiovascular outcomes postpartum.

[1]  L. Laurent,et al.  Histopathologic and Transcriptomic Profiling Identifies Novel Trophoblast Defects in Patients With Preeclampsia and Maternal Vascular Malperfusion. , 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2]  Jessica L. Faulkner,et al.  Mechanisms of leptin-induced endothelial dysfunction , 2022, Current opinion in nephrology and hypertension.

[3]  G. P. Morris,et al.  Human Leukocyte Antigens in Pregnancy and Preeclampsia , 2022, Frontiers in Genetics.

[4]  J. Whitin,et al.  Early-pregnancy prediction of risk for pre-eclampsia using maternal blood leptin/ceramide ratio: discovery and confirmation , 2021, BMJ Open.

[5]  Paul D. W. Kirk,et al.  The RNA landscape of the human placenta in health and disease , 2021, Nature communications.

[6]  M. Christiansen,et al.  The Role of Leptin in Fetal Growth during Pre-Eclampsia , 2021, International journal of molecular sciences.

[7]  R. Redline,et al.  Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus , 2021, Modern Pathology.

[8]  M. Brizzi,et al.  The Inflammatory Cytokine IL-3 Hampers Cardioprotection Mediated by Endothelial Cell-Derived Extracellular Vesicles Possibly via Their Protein Cargo , 2020, Cells.

[9]  P. Schulze,et al.  Characterization of dendritic cells in human and experimental myocarditis , 2020, ESC heart failure.

[10]  E. Flowers,et al.  Socioeconomic Status, Preeclampsia Risk and Gestational Length in Black and White Women , 2019, Journal of Racial and Ethnic Health Disparities.

[11]  Brandon K. Fornwalt,et al.  Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants. , 2019, Circulation.

[12]  K. Renner,et al.  IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils , 2019, The Journal of Immunology.

[13]  Jason D. Wright,et al.  Preeclampsia outcomes at delivery and race , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[14]  P. Libby,et al.  Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis , 2019, The Journal of experimental medicine.

[15]  R. Chettier,et al.  Cardiomyopathy and Preeclampsia: Shared Genetics? , 2018, Circulation.

[16]  B. Cox,et al.  Epigenetic regulation of placental gene expression in transcriptional subtypes of preeclampsia , 2018, Clinical Epigenetics.

[17]  M. Dottore,et al.  A dual role for the N-terminal domain of the IL-3 receptor in cell signalling , 2018, Nature Communications.

[18]  David M. Jones,et al.  Therapeutic effect of anti-IL-5 on eosinophilic myocarditis with large pericardial effusion , 2017, BMJ Case Reports.

[19]  A. Caughey,et al.  The Impact of maternal obesity and race/ethnicity on perinatal outcomes: Independent and joint effects , 2016, Obesity.

[20]  Neil J Sebire,et al.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.

[21]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[22]  S. Brennecke,et al.  Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. , 2016, The New England journal of medicine.

[23]  J. Kere,et al.  Gene expression profiling of pre-eclamptic placentae by RNA sequencing , 2015, Scientific Reports.

[24]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[25]  Nancy Wilkins-Diehr,et al.  XSEDE: Accelerating Scientific Discovery , 2014, Computing in Science & Engineering.

[26]  I. Sjaastad,et al.  Circulating cytokine levels in mice with heart failure are etiology dependent. , 2010, Journal of applied physiology.

[27]  A. Hamann,et al.  Regulation of energy balance by leptin. , 2009, Experimental and clinical endocrinology & diabetes.

[28]  E. Birney,et al.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.

[29]  W. Alkema,et al.  BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams , 2008, BMC Genomics.

[30]  K. Sliwa,et al.  A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy , 2007, Cell.

[31]  A. Erbay,et al.  Role of Novel Mediators of Inflammation in Left Ventricular Remodeling in Patients With Acute Myocardial Infarction: Do They Affect the Outcome of Patients? , 2007, Angiology.

[32]  Yuko Ito,et al.  Mechanism of Inflammation in Murine Eosinophilic Myocarditis Produced by Adoptive Transfer with Ovalbumin Challenge , 2006, International Archives of Allergy and Immunology.

[33]  A. Moffett,et al.  Immunology of placentation in eutherian mammals , 2006, Nature Reviews Immunology.

[34]  Diethelm Wallwiener,et al.  High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. , 2005, American journal of obstetrics and gynecology.

[35]  G. Escobar,et al.  Maternal Ethnicity, Paternal Ethnicity, and Parental Ethnic Discordance: Predictors of Preeclampsia , 2005, Obstetrics and gynecology.

[36]  A. Nocera,et al.  Cytotoxic molecule mRNA expression in chronically rejected human kidney allografts. , 2005, Transplantation proceedings.

[37]  F. Balloux,et al.  Pathogen-Driven Selection and Worldwide HLA Class I Diversity , 2005, Current Biology.

[38]  E. Lieberman,et al.  Patterns of Pregnancy-Related Hypertension in Black and White Women , 2005, Hypertension in pregnancy.

[39]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.

[40]  R. Berkowitz,et al.  The Changing Clinical Presentation of Complete Molar Pregnancy , 1995, Obstetrics and gynecology.

[41]  M. Copin,et al.  Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. , 1993, Blood.

[42]  Anil Mishra,et al.  IL-5 overexpression induced blood eosinophilia associated progression of cardiac abnormalities. , 2022, International journal of basic and clinical immunology.

[43]  K. Stergiopoulos,et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[44]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[45]  M. Gulati,et al.  Differences in preeclampsia rates between African American and Caucasian women: trends from the National Hospital Discharge Survey. , 2014, Journal of women's health.

[46]  S. Isezuo,et al.  Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. , 2007, Ethnicity & disease.